SlideShare una empresa de Scribd logo
1 de 36
Disclosure of Conflict of Interest
I Dr. AHMAD SALADDIN SULTAN
DO NOT have a financial interest/arrangement or affiliation
with anyone in relation to this
program/presentation/organization that could be perceived as
a real or apparent conflict of interest in the context of the
subject of this presentation.
Neurological Emergencies
Dr.Ahmad Saladdin Sultan
Specialist Emergency Medicine
M.B.Ch.B, M.R.C.E.M, F.J.M.C.H.S(A&E)
PART ONE
HEADACHE
Headache is pain in any region of the head.
Headaches may occur on one or both sides of the head,
be isolated to a certain location, radiate across the head
from one point.
• As many as 90 percent of all benign headaches fall under a few categories,
including migraine, tension-type, cluster, and chronic daily headache.
While episodic tension-type headache is the most frequent headache type
in population-based studies, migraine is the most common diagnosis in
patients presenting to primary care physicians with headache. The one-
year prevalence of episodic tension-type headache (TTH) is approximately
65 percent, but most people with tension-type headache do not present
to physicians for care.
• Cluster headache typically leads to significant disability and most of these
patients will come to medical attention. However, cluster headache
remains an uncommon diagnosis in primary care settings because of
overall low prevalence in the general population (<1 percent).
• Primary Headache : of unknown cause
Symptom Migraine Tension-type Cluster
Location
Adults: Unilateral in 60 to
70 percent, bifrontal or
global in 30 percent
Children and adolescents:
Bilateral in majority
Bilateral
Always unilateral, usually
begins around the eye or
temple
Characteristics
Gradual in onset,
crescendo pattern;
pulsating; moderate or
severe intensity;
aggravated by routine
physical activity
Pressure or tightness
which waxes and wanes
Pain begins quickly,
reaches a crescendo
within minutes; pain is
deep, continuous and
explosive in quality
Patient appearance
Patient prefers to rest in
a dark, quiet room
Patient may remain
active or may need to
rest
Patient remains active
Secondary Headache : there is a cause
History: The gold standard for diagnosis and management of headache.
A thorough history can focus the physical examination and determine the need for further
investigations and neuroimaging studies. A systematic history should include the following:
●Age at onset
●Presence or absence of aura and prodrome
●Frequency, intensity, and duration of attack
●Number of headache days per month
●Time and mode of onset
●Quality, site, and radiation of pain
●Associated symptoms and abnormalities
●Family history of migraine
●Precipitating and relieving factors
●Effect of activity on pain
●Relationship with food/alcohol
●Response to any previous treatment
●Any recent change in vision
●Association with recent trauma
The examination of an adult with headache complaints should cover the following
areas:
• Obtain blood pressure and pulse
• Listen for bruit at neck, eyes, and head for clinical signs of arteriovenous
malformation
• Palpate the head, neck, and shoulder regions
• Check temporal and neck arteries
• Examine the spine and neck muscles
The neurologic examination should cover mental status testing, cranial nerve
examination, funduscopy and otoscopy, and symmetry on motor, reflex, cerebellar
(coordination), and sensory tests.
MIGRAINE:
A. At least 5 attacks fulfilling criteria B–D
B. Headache attacks lasting 4-72 hours (untreated or unsuccessfully treated)
C. Headache has at least 2 of the following characteristics:
• 1. unilateral location
• 2. pulsating quality
• 3. moderate or severe pain intensity
• 4. aggravation by or causing avoidance of routine
physical activity (eg, walking or climbing stairs)
D. During headache at least 1 of the following:
• 1. nausea and/or vomiting
• 2. photophobia and phonophobia
• E. Not attributed to another disorder
The International Classification of Headache Disorders (ICHD)
TENSION HEADACHE:
A. At least 10 episodes occurring on <1 day/month on average (<12 days/year) and
fulfilling criteria B–D
B. Headache lasting from 30 minutes to 7 days
C. Headache has at least 2 of the following characteristics:
• 1. bilateral location
• 2. pressing/tightening (non-pulsating) quality
• 3. mild or moderate intensity
• 4. not aggravated by routine physical activity such as walking or climbing stairs
D. Both of the following:
• 1. no nausea or vomiting (anorexia may occur)
• 2. no more than one of photophobia or phonophobia
• E. Not attributed to another disorder
The International Classification of Headache Disorders (ICHD)
CLUSTER HEADACHE:
A. At least 5 attacks fulfilling criteria B–D
B. Severe or very severe unilateral orbital, supraorbital and/or temporal pain lasting
15-180 minutes if untreated
C. Headache is accompanied by at least 1 of the following:
• 1. ipsilateral conjunctival injection and/or lacrimation
• 2. ipsilateral nasal congestion and/or rhinorrhoea
• 3. ipsilateral eyelid oedema
• 4. ipsilateral forehead and facial sweating
• 5. ipsilateral miosis and/or ptosis
• 6. a sense of restlessness or agitation
D. Attacks have a frequency from 1 every other day to 8/day
E. Not attributed to another disorder
The International Classification of Headache Disorders (ICHD)
Paying attention to danger signs is important since headaches may be the presenting
symptom of a space-occupying mass or vascular lesion, infection, metabolic disturbance, or a
systemic problem. The following features in the history can serve as warning signs of possible
serious underlying disease.
The mnemonic SNOOP is a reminder of the danger signs ("red flags") for the presence of serious
underlying disorders that can cause acute or sub-acute headache :
●Systemic symptoms, illness, or condition (eg, fever, weight loss, cancer, pregnancy,
immunocompromised state including HIV).
●Neurologic symptoms or abnormal signs (eg, confusion, impaired alertness or consciousness,
papilledema, focal neurologic symptoms or signs, meningismus, or seizures).
●Onset is new (particularly for age >40 years) or sudden (eg, "thunderclap").
●Other associated conditions or features (eg, head trauma, illicit drug use, or toxic exposure;
headache. awakens from sleep, is worse with Valsalva maneuvers, or is precipitated by cough,
exertion, or sexual activity).
●Previous headache history with headache progression or change in attack frequency, severity,
or clinical features.
TENSION HEADACHE
• The usual abortive treatment can be any simple analgesic (aspirin, NSAIDs, acetaminophen).
The most effective prophylactic drug is amitriptyline in the dosage of 50–150 mg per day.
Lower dosage may be tried initially.
MIGRAINE HEADACHE
• There are certain specific treatments for migraines, which are given as follows:
• • Analgesics: Aspirin, acetaminophen
• • NSAIDs: Naproxen, ibuprofen
• • 5-HT1 agonists-oral: Ergotamine, rizatriptan, naratriptan, zolmitriptan
• • 5-HT1 agonists-nasal: Dihydroergotamine, sumatriptan, zolmitriptan
• • 5-HT1 agonists-parenteral: Dihydroergotamine, sumatriptan
• • Dopamine antagonists: Metoclopramide, prochlorperazine.
CLUSTER HEADACHE
• Nasal oxygen (8–10 L/min), sumatriptan (subcutaneous 6 mg) and dihydroergotamine
(subcutaneous or intramuscular).
• The maintenance prophylactic agents include calcium channel blockers (verapamil 80 mg
three times a day to a maximum dose of 720 mg per day; monitor with ECG if total daily
dose is more than 480 mg/ day), methylsergide, lithium (300 mg three times daily; monitor
with lithium levels), topiramate (100–400 mg/day), gabapentine (1,200–3,600 mg/day),
melatonin (9–12 mg/day).
PART TWO
Bell’s Palsy
Acute peripheral CN VII (facial nerve) palsy of unknown cause.
However, the terms "Bell's palsy" and "idiopathic facial paralysis" may no
longer be considered. A peripheral facial palsy is a clinical syndrome of
many causes.
Sir Charles Bell, Scottish Surgeon First described in early 1800s based on
trauma to facial nerves.
Bell's palsy, defined as an acute peripheral facial nerve palsy of
unknown cause, represents about half of all cases of facial nerve
palsy . The annual incidence rate is between 13 and 34 cases per
100,000 population . There is no race, geographic, or gender
predilection, but the risk is three times greater during pregnancy,
especially in the third trimester or in the first postpartum week.
Diabetes is present in about 5 to 10 percent of patients.
-Herpes simplex Virus now is widely accepted as most common cause.
-Herpes zoster is probably the second most common viral infection associated
with facial palsy.
-An inactivated intranasal influenza vaccine.
-Genetic predisposition in some cases.
-Diabetes is a risk factor for microangiopathy.
-The increased risk of Bell’s palsy associated with pregnancy, which is most
marked in the third trimester and the first postpartum week, may be caused
by pregnancy-related fluid retention leading to compression of the nerve or
perineural edema.
-Patients with Bell's palsy typically present with the sudden onset (usually over hours) of
unilateral facial paralysis.
-Common findings include the eyebrow sagging, inability to close the eye, disappearance of the
nasolabial fold, and drooping at the affected corner of the mouth, which is drawn to the
unaffected side.
-Decreased tearing, hyperacusis, and/or loss of taste sensation on the anterior two-thirds of the
tongue may help to site the lesion in the fallopian canal, but these findings are of little practical
use other than as indicators of severity.
-patients had bilateral facial palsy, possibly from the same pathogenesis as typical unilateral Bell's
palsy.
Examination : Facial movement is assessed by observing the response to command for closing
the eyes, elevating the brow, frowning, showing the teeth, puckering the lips, and tensing the soft
tissues of the neck to observe for platysma activation. The evaluation also includes a general
physical examination and neurologic examination. Particular attention is directed at the external
ear to look for vesicles or scabbing (which indicates zoster) and for mass lesions within the
parotid gland.
Thus, dissociation of movement of the face to command from
spontaneous movement, as in smiling, indicates an upper motor neuron
lesion. Lack of dissociation (absence of both voluntary and spontaneous
movement) indicates a lower motor neuron (peripheral) lesion.
-Herpes zoster (Ramsey Hunt syndrome).
-Otitis media.
-Lyme disease: could be Bilateral.
-Guillain-Barré syndrome: could be bilateral.
-HIV infection: could be bilateral.
-Sarcoidosis: could be bilateral.
-Tumor.
-Trauma.
-Stroke.
• oral glucocorticoids for all patients with idiopathic facial nerve palsy (Bell's
palsy) or facial nerve palsy of suspected viral etiology, consistent with
current guidelines. Treatment should preferably begin within three days of
symptom onset. Our suggested regimen is prednisone (60 to
80 mg/day) for one week.
• The suspicion that Bell's palsy is caused by herpes simplex virus in most
patients led to trials of antiviral therapy.
• Suggested early combined therapy with prednisone (60 to 80 mg per day)
plus valacyclovir (1000 mg three times daily) for one week for patients
with severe facial palsy at presentation.
• Eye care In severe cases of Bell's palsy, the cornea may be at risk because
of poor eye lid closure and reduced tearing.
• The prognosis of Bell's palsy is related to the severity of the lesion. A
simple rule is that clinically incomplete lesions tend to recover.
• The prognosis is favorable if some recovery is seen within the first 21 days
of onset. A diagnosis of Bell's palsy is doubtful if some facial function,
however small, has not returned within three to four months.
PART THREE
SEIZURE
Seizures are a common occurrence, affecting an estimated 8 to 10
percent of the population over a lifetime.
Seizures account for 1 to 2 percent of all emergency department
visits, and approximately one-quarter of these will be a first seizure
A seizure is a sudden change in behavior caused by electrical
hypersynchronization of neuronal networks in the cerebral cortex.
• Acute symptomatic seizure — Refers to a seizure that occurs at the time
of a systemic insult or in close temporal association with a documented
brain insult . Such insults include metabolic derangements, drug or alcohol
withdrawal, and acute neurologic disorders such as stroke, encephalitis, or
acute head injury.
• Unprovoked seizure — Refers to a seizure of unknown etiology as well as
one that occurs in relation to a preexisting brain lesion or progressive
nervous system disorder. Unprovoked seizures that are determined to be
due to an underlying brain lesion or disorder are also referred to as
remote symptomatic seizures. They carry a higher risk of future epilepsy
compared with acute symptomatic seizures.
-Focal seizures with retained awareness — The symptoms of focal seizures
with retained awareness (previously called simple partial seizures) vary from
one patient to another and depend entirely on the part of the cortex that is
disrupted at the onset of the seizure.
-Focal seizures with impaired awareness — Some focal seizures are
associated with altered awareness at the onset of the seizure or as it
progresses. These seizures, previously called complex partial seizures, are the
most common type of seizure in adults with epilepsy.
-Generalized seizures — Generalized tonic-clonic seizures (also called grand
mal seizures, major motor seizures, or convulsions) are the most common
type of generalized seizures.
Seizure is primarily a clinical diagnosis, and accurate diagnosis requires
differentiating seizure from other common clinical events that can mimic
seizure.
In adults, the primary conditions to consider in patients presenting with
transient or paroxysmal neurologic events are
●Syncope
●Transient ischemic attack (particularly in older adults)
●Migraine
●Panic attack and anxiety
●Psychogenic nonepileptic seizure
●Paroxysmal movement disorders
Medical history
Description of the event
Postictal period
Seizure precipitants or triggers
Prior events
Medications and substances
Past medical history
Family history
Physical and neurologic examination
Laboratories
Electrocardiogram
ADDITIONAL TESTING
Early postseizure management — Most seizures remit spontaneously within two
minutes and rapid administration of a benzodiazepine or antiseizure drug is not
required. Nonetheless, intravenous access is typically secured by paramedics or in
the emergency department setting for patients presenting acutely so that
parenteral medications can be administered if the seizure is more prolonged or
recurs.
When to start antiseizure drug therapy — The decision whether to start
antiseizure drug therapy immediately after a first seizure depends on multiple
factors, including the probability that the event represented a seizure, the
suspected or confirmed cause of the seizure based on the initial evaluation, the
stability of the patient, and the estimated risk of recurrent seizure.
Indications for hospitalization — Hospitalization may be required for patients
who have a first seizure associated with a prolonged postictal state, incomplete
recovery, or serious seizure-related injury. Other indications for hospitalization
include status epilepticus, the presence of a neurologic or systemic illness or insult
requiring additional evaluation and treatment, or questions regarding compliance.
Questions?

Más contenido relacionado

La actualidad más candente

La actualidad más candente (20)

Headaches Lecture
Headaches LectureHeadaches Lecture
Headaches Lecture
 
Headache
HeadacheHeadache
Headache
 
Approach to a_case_of_headache
Approach to a_case_of_headacheApproach to a_case_of_headache
Approach to a_case_of_headache
 
Headache
HeadacheHeadache
Headache
 
An Approach to a Patient with Headache
An Approach to a Patient with HeadacheAn Approach to a Patient with Headache
An Approach to a Patient with Headache
 
Headache
HeadacheHeadache
Headache
 
Headache
HeadacheHeadache
Headache
 
migraine management guidelines )
migraine management guidelines )migraine management guidelines )
migraine management guidelines )
 
Headache
HeadacheHeadache
Headache
 
Headache Feb 2016
Headache Feb 2016Headache Feb 2016
Headache Feb 2016
 
Headache
HeadacheHeadache
Headache
 
Management of headache
Management of headacheManagement of headache
Management of headache
 
Trigeminal Autonomic Cephalalgias
Trigeminal Autonomic CephalalgiasTrigeminal Autonomic Cephalalgias
Trigeminal Autonomic Cephalalgias
 
Primary headache
Primary headachePrimary headache
Primary headache
 
Headache & Facial pain
Headache & Facial painHeadache & Facial pain
Headache & Facial pain
 
Headache
HeadacheHeadache
Headache
 
Migraine its presentation and management
Migraine  its presentation and managementMigraine  its presentation and management
Migraine its presentation and management
 
Approach to headaches
Approach to headachesApproach to headaches
Approach to headaches
 
Pediatric migraine
Pediatric migrainePediatric migraine
Pediatric migraine
 
Headaches
Headaches  Headaches
Headaches
 

Similar a Headache primary and secondary

Clinical study of Migraine
Clinical study of MigraineClinical study of Migraine
Clinical study of Migrainesyeddastagir9
 
4 headache jaber amin
4 headache  jaber amin4 headache  jaber amin
4 headache jaber aminJaber Manasia
 
Headache Syndromes presentation Dr. Tarek .pptx
Headache Syndromes presentation Dr. Tarek .pptxHeadache Syndromes presentation Dr. Tarek .pptx
Headache Syndromes presentation Dr. Tarek .pptxAhmedalmahdi16
 
Pediatric headache by dr. milind bapat
Pediatric headache by dr. milind bapatPediatric headache by dr. milind bapat
Pediatric headache by dr. milind bapatMilind Bapat
 
Lecture on Pediatric headache.pptx
Lecture on Pediatric headache.pptxLecture on Pediatric headache.pptx
Lecture on Pediatric headache.pptxMarthaBolanos
 
Headache in Children.pptx
Headache in Children.pptxHeadache in Children.pptx
Headache in Children.pptxJwan AlSofi
 
HEADACHE SLIIDE SHARE.pptx primary headache
HEADACHE SLIIDE SHARE.pptx primary headacheHEADACHE SLIIDE SHARE.pptx primary headache
HEADACHE SLIIDE SHARE.pptx primary headacheASHISH KUMAR
 
Practical Approach to headache
Practical  Approach to headachePractical  Approach to headache
Practical Approach to headacheDr Surendra Khosya
 
Approach to the diagnosis and management of primary headache disorders-GP-rec...
Approach to the diagnosis and management of primary headache disorders-GP-rec...Approach to the diagnosis and management of primary headache disorders-GP-rec...
Approach to the diagnosis and management of primary headache disorders-GP-rec...Adamu Mohammad
 
Approach to the diagnosis and management of primary headache disorders-GP-rec...
Approach to the diagnosis and management of primary headache disorders-GP-rec...Approach to the diagnosis and management of primary headache disorders-GP-rec...
Approach to the diagnosis and management of primary headache disorders-GP-rec...Adamu Mohammad
 
The common bane of head pain
The common bane of head painThe common bane of head pain
The common bane of head painshreyahospital
 
Migraine and Tension Headache Diagnosis and Treatment Guideline
Migraine and Tension Headache Diagnosis and Treatment GuidelineMigraine and Tension Headache Diagnosis and Treatment Guideline
Migraine and Tension Headache Diagnosis and Treatment GuidelineUtai Sukviwatsirikul
 

Similar a Headache primary and secondary (20)

Headache
HeadacheHeadache
Headache
 
Clinical study of Migraine
Clinical study of MigraineClinical study of Migraine
Clinical study of Migraine
 
4 headache jaber amin
4 headache  jaber amin4 headache  jaber amin
4 headache jaber amin
 
Headache
HeadacheHeadache
Headache
 
Headache Syndromes presentation Dr. Tarek .pptx
Headache Syndromes presentation Dr. Tarek .pptxHeadache Syndromes presentation Dr. Tarek .pptx
Headache Syndromes presentation Dr. Tarek .pptx
 
Pediatric headache by dr. milind bapat
Pediatric headache by dr. milind bapatPediatric headache by dr. milind bapat
Pediatric headache by dr. milind bapat
 
Lecture on Pediatric headache.pptx
Lecture on Pediatric headache.pptxLecture on Pediatric headache.pptx
Lecture on Pediatric headache.pptx
 
HEADACHE GANTA-IMA.pptx
HEADACHE GANTA-IMA.pptxHEADACHE GANTA-IMA.pptx
HEADACHE GANTA-IMA.pptx
 
Headache in Children.pptx
Headache in Children.pptxHeadache in Children.pptx
Headache in Children.pptx
 
HEADACHE SLIIDE SHARE.pptx primary headache
HEADACHE SLIIDE SHARE.pptx primary headacheHEADACHE SLIIDE SHARE.pptx primary headache
HEADACHE SLIIDE SHARE.pptx primary headache
 
Headaches, All you need to know
Headaches, All you need to knowHeadaches, All you need to know
Headaches, All you need to know
 
Headache ; dr jayesh
Headache  ; dr jayeshHeadache  ; dr jayesh
Headache ; dr jayesh
 
Practical Approach to headache
Practical  Approach to headachePractical  Approach to headache
Practical Approach to headache
 
Approach to the diagnosis and management of primary headache disorders-GP-rec...
Approach to the diagnosis and management of primary headache disorders-GP-rec...Approach to the diagnosis and management of primary headache disorders-GP-rec...
Approach to the diagnosis and management of primary headache disorders-GP-rec...
 
Approach to the diagnosis and management of primary headache disorders-GP-rec...
Approach to the diagnosis and management of primary headache disorders-GP-rec...Approach to the diagnosis and management of primary headache disorders-GP-rec...
Approach to the diagnosis and management of primary headache disorders-GP-rec...
 
Headache
HeadacheHeadache
Headache
 
The common bane of head pain
The common bane of head painThe common bane of head pain
The common bane of head pain
 
CNS.ppt
CNS.pptCNS.ppt
CNS.ppt
 
Migraine and Tension Headache Diagnosis and Treatment Guideline
Migraine and Tension Headache Diagnosis and Treatment GuidelineMigraine and Tension Headache Diagnosis and Treatment Guideline
Migraine and Tension Headache Diagnosis and Treatment Guideline
 
Migraine
Migraine Migraine
Migraine
 

Último

call girls in green park DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
call girls in green park  DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️call girls in green park  DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
call girls in green park DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️saminamagar
 
COVID-19 (NOVEL CORONA VIRUS DISEASE PANDEMIC ).pptx
COVID-19  (NOVEL CORONA  VIRUS DISEASE PANDEMIC ).pptxCOVID-19  (NOVEL CORONA  VIRUS DISEASE PANDEMIC ).pptx
COVID-19 (NOVEL CORONA VIRUS DISEASE PANDEMIC ).pptxBibekananda shah
 
Measurement of Radiation and Dosimetric Procedure.pptx
Measurement of Radiation and Dosimetric Procedure.pptxMeasurement of Radiation and Dosimetric Procedure.pptx
Measurement of Radiation and Dosimetric Procedure.pptxDr. Dheeraj Kumar
 
Apiculture Chapter 1. Introduction 2.ppt
Apiculture Chapter 1. Introduction 2.pptApiculture Chapter 1. Introduction 2.ppt
Apiculture Chapter 1. Introduction 2.pptkedirjemalharun
 
Primary headache and facial pain. (2024)
Primary headache and facial pain. (2024)Primary headache and facial pain. (2024)
Primary headache and facial pain. (2024)Mohamed Rizk Khodair
 
Report Back from SGO: What’s New in Uterine Cancer?.pptx
Report Back from SGO: What’s New in Uterine Cancer?.pptxReport Back from SGO: What’s New in Uterine Cancer?.pptx
Report Back from SGO: What’s New in Uterine Cancer?.pptxbkling
 
Introduction to Sports Injuries by- Dr. Anjali Rai
Introduction to Sports Injuries by- Dr. Anjali RaiIntroduction to Sports Injuries by- Dr. Anjali Rai
Introduction to Sports Injuries by- Dr. Anjali RaiGoogle
 
See the 2,456 pharmacies on the National E-Pharmacy Platform
See the 2,456 pharmacies on the National E-Pharmacy PlatformSee the 2,456 pharmacies on the National E-Pharmacy Platform
See the 2,456 pharmacies on the National E-Pharmacy PlatformKweku Zurek
 
Presentation on Parasympathetic Nervous System
Presentation on Parasympathetic Nervous SystemPresentation on Parasympathetic Nervous System
Presentation on Parasympathetic Nervous SystemPrerana Jadhav
 
The next social challenge to public health: the information environment.pptx
The next social challenge to public health:  the information environment.pptxThe next social challenge to public health:  the information environment.pptx
The next social challenge to public health: the information environment.pptxTina Purnat
 
call girls in Dwarka Sector 21 Metro DELHI 🔝 >༒9540349809 🔝 genuine Escort Se...
call girls in Dwarka Sector 21 Metro DELHI 🔝 >༒9540349809 🔝 genuine Escort Se...call girls in Dwarka Sector 21 Metro DELHI 🔝 >༒9540349809 🔝 genuine Escort Se...
call girls in Dwarka Sector 21 Metro DELHI 🔝 >༒9540349809 🔝 genuine Escort Se...saminamagar
 
world health day presentation ppt download
world health day presentation ppt downloadworld health day presentation ppt download
world health day presentation ppt downloadAnkitKumar311566
 
Biomechanics- Shoulder Joint!!!!!!!!!!!!
Biomechanics- Shoulder Joint!!!!!!!!!!!!Biomechanics- Shoulder Joint!!!!!!!!!!!!
Biomechanics- Shoulder Joint!!!!!!!!!!!!ibtesaam huma
 
History and Development of Pharmacovigilence.pdf
History and Development of Pharmacovigilence.pdfHistory and Development of Pharmacovigilence.pdf
History and Development of Pharmacovigilence.pdfSasikiranMarri
 
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaur
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaurMETHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaur
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaurNavdeep Kaur
 
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic AnalysisVarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic AnalysisGolden Helix
 
epilepsy and status epilepticus for undergraduate.pptx
epilepsy and status epilepticus  for undergraduate.pptxepilepsy and status epilepticus  for undergraduate.pptx
epilepsy and status epilepticus for undergraduate.pptxMohamed Rizk Khodair
 
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...Badalona Serveis Assistencials
 
Presentation on General Anesthetics pdf.
Presentation on General Anesthetics pdf.Presentation on General Anesthetics pdf.
Presentation on General Anesthetics pdf.Prerana Jadhav
 

Último (20)

call girls in green park DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
call girls in green park  DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️call girls in green park  DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
call girls in green park DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
 
COVID-19 (NOVEL CORONA VIRUS DISEASE PANDEMIC ).pptx
COVID-19  (NOVEL CORONA  VIRUS DISEASE PANDEMIC ).pptxCOVID-19  (NOVEL CORONA  VIRUS DISEASE PANDEMIC ).pptx
COVID-19 (NOVEL CORONA VIRUS DISEASE PANDEMIC ).pptx
 
Measurement of Radiation and Dosimetric Procedure.pptx
Measurement of Radiation and Dosimetric Procedure.pptxMeasurement of Radiation and Dosimetric Procedure.pptx
Measurement of Radiation and Dosimetric Procedure.pptx
 
Epilepsy
EpilepsyEpilepsy
Epilepsy
 
Apiculture Chapter 1. Introduction 2.ppt
Apiculture Chapter 1. Introduction 2.pptApiculture Chapter 1. Introduction 2.ppt
Apiculture Chapter 1. Introduction 2.ppt
 
Primary headache and facial pain. (2024)
Primary headache and facial pain. (2024)Primary headache and facial pain. (2024)
Primary headache and facial pain. (2024)
 
Report Back from SGO: What’s New in Uterine Cancer?.pptx
Report Back from SGO: What’s New in Uterine Cancer?.pptxReport Back from SGO: What’s New in Uterine Cancer?.pptx
Report Back from SGO: What’s New in Uterine Cancer?.pptx
 
Introduction to Sports Injuries by- Dr. Anjali Rai
Introduction to Sports Injuries by- Dr. Anjali RaiIntroduction to Sports Injuries by- Dr. Anjali Rai
Introduction to Sports Injuries by- Dr. Anjali Rai
 
See the 2,456 pharmacies on the National E-Pharmacy Platform
See the 2,456 pharmacies on the National E-Pharmacy PlatformSee the 2,456 pharmacies on the National E-Pharmacy Platform
See the 2,456 pharmacies on the National E-Pharmacy Platform
 
Presentation on Parasympathetic Nervous System
Presentation on Parasympathetic Nervous SystemPresentation on Parasympathetic Nervous System
Presentation on Parasympathetic Nervous System
 
The next social challenge to public health: the information environment.pptx
The next social challenge to public health:  the information environment.pptxThe next social challenge to public health:  the information environment.pptx
The next social challenge to public health: the information environment.pptx
 
call girls in Dwarka Sector 21 Metro DELHI 🔝 >༒9540349809 🔝 genuine Escort Se...
call girls in Dwarka Sector 21 Metro DELHI 🔝 >༒9540349809 🔝 genuine Escort Se...call girls in Dwarka Sector 21 Metro DELHI 🔝 >༒9540349809 🔝 genuine Escort Se...
call girls in Dwarka Sector 21 Metro DELHI 🔝 >༒9540349809 🔝 genuine Escort Se...
 
world health day presentation ppt download
world health day presentation ppt downloadworld health day presentation ppt download
world health day presentation ppt download
 
Biomechanics- Shoulder Joint!!!!!!!!!!!!
Biomechanics- Shoulder Joint!!!!!!!!!!!!Biomechanics- Shoulder Joint!!!!!!!!!!!!
Biomechanics- Shoulder Joint!!!!!!!!!!!!
 
History and Development of Pharmacovigilence.pdf
History and Development of Pharmacovigilence.pdfHistory and Development of Pharmacovigilence.pdf
History and Development of Pharmacovigilence.pdf
 
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaur
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaurMETHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaur
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaur
 
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic AnalysisVarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
 
epilepsy and status epilepticus for undergraduate.pptx
epilepsy and status epilepticus  for undergraduate.pptxepilepsy and status epilepticus  for undergraduate.pptx
epilepsy and status epilepticus for undergraduate.pptx
 
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...
 
Presentation on General Anesthetics pdf.
Presentation on General Anesthetics pdf.Presentation on General Anesthetics pdf.
Presentation on General Anesthetics pdf.
 

Headache primary and secondary

  • 1. Disclosure of Conflict of Interest I Dr. AHMAD SALADDIN SULTAN DO NOT have a financial interest/arrangement or affiliation with anyone in relation to this program/presentation/organization that could be perceived as a real or apparent conflict of interest in the context of the subject of this presentation.
  • 2. Neurological Emergencies Dr.Ahmad Saladdin Sultan Specialist Emergency Medicine M.B.Ch.B, M.R.C.E.M, F.J.M.C.H.S(A&E)
  • 4. Headache is pain in any region of the head. Headaches may occur on one or both sides of the head, be isolated to a certain location, radiate across the head from one point.
  • 5. • As many as 90 percent of all benign headaches fall under a few categories, including migraine, tension-type, cluster, and chronic daily headache. While episodic tension-type headache is the most frequent headache type in population-based studies, migraine is the most common diagnosis in patients presenting to primary care physicians with headache. The one- year prevalence of episodic tension-type headache (TTH) is approximately 65 percent, but most people with tension-type headache do not present to physicians for care. • Cluster headache typically leads to significant disability and most of these patients will come to medical attention. However, cluster headache remains an uncommon diagnosis in primary care settings because of overall low prevalence in the general population (<1 percent).
  • 6. • Primary Headache : of unknown cause Symptom Migraine Tension-type Cluster Location Adults: Unilateral in 60 to 70 percent, bifrontal or global in 30 percent Children and adolescents: Bilateral in majority Bilateral Always unilateral, usually begins around the eye or temple Characteristics Gradual in onset, crescendo pattern; pulsating; moderate or severe intensity; aggravated by routine physical activity Pressure or tightness which waxes and wanes Pain begins quickly, reaches a crescendo within minutes; pain is deep, continuous and explosive in quality Patient appearance Patient prefers to rest in a dark, quiet room Patient may remain active or may need to rest Patient remains active
  • 7. Secondary Headache : there is a cause
  • 8. History: The gold standard for diagnosis and management of headache. A thorough history can focus the physical examination and determine the need for further investigations and neuroimaging studies. A systematic history should include the following: ●Age at onset ●Presence or absence of aura and prodrome ●Frequency, intensity, and duration of attack ●Number of headache days per month ●Time and mode of onset ●Quality, site, and radiation of pain ●Associated symptoms and abnormalities ●Family history of migraine ●Precipitating and relieving factors ●Effect of activity on pain ●Relationship with food/alcohol ●Response to any previous treatment ●Any recent change in vision ●Association with recent trauma
  • 9. The examination of an adult with headache complaints should cover the following areas: • Obtain blood pressure and pulse • Listen for bruit at neck, eyes, and head for clinical signs of arteriovenous malformation • Palpate the head, neck, and shoulder regions • Check temporal and neck arteries • Examine the spine and neck muscles The neurologic examination should cover mental status testing, cranial nerve examination, funduscopy and otoscopy, and symmetry on motor, reflex, cerebellar (coordination), and sensory tests.
  • 10. MIGRAINE: A. At least 5 attacks fulfilling criteria B–D B. Headache attacks lasting 4-72 hours (untreated or unsuccessfully treated) C. Headache has at least 2 of the following characteristics: • 1. unilateral location • 2. pulsating quality • 3. moderate or severe pain intensity • 4. aggravation by or causing avoidance of routine physical activity (eg, walking or climbing stairs) D. During headache at least 1 of the following: • 1. nausea and/or vomiting • 2. photophobia and phonophobia • E. Not attributed to another disorder The International Classification of Headache Disorders (ICHD)
  • 11. TENSION HEADACHE: A. At least 10 episodes occurring on <1 day/month on average (<12 days/year) and fulfilling criteria B–D B. Headache lasting from 30 minutes to 7 days C. Headache has at least 2 of the following characteristics: • 1. bilateral location • 2. pressing/tightening (non-pulsating) quality • 3. mild or moderate intensity • 4. not aggravated by routine physical activity such as walking or climbing stairs D. Both of the following: • 1. no nausea or vomiting (anorexia may occur) • 2. no more than one of photophobia or phonophobia • E. Not attributed to another disorder The International Classification of Headache Disorders (ICHD)
  • 12. CLUSTER HEADACHE: A. At least 5 attacks fulfilling criteria B–D B. Severe or very severe unilateral orbital, supraorbital and/or temporal pain lasting 15-180 minutes if untreated C. Headache is accompanied by at least 1 of the following: • 1. ipsilateral conjunctival injection and/or lacrimation • 2. ipsilateral nasal congestion and/or rhinorrhoea • 3. ipsilateral eyelid oedema • 4. ipsilateral forehead and facial sweating • 5. ipsilateral miosis and/or ptosis • 6. a sense of restlessness or agitation D. Attacks have a frequency from 1 every other day to 8/day E. Not attributed to another disorder The International Classification of Headache Disorders (ICHD)
  • 13. Paying attention to danger signs is important since headaches may be the presenting symptom of a space-occupying mass or vascular lesion, infection, metabolic disturbance, or a systemic problem. The following features in the history can serve as warning signs of possible serious underlying disease. The mnemonic SNOOP is a reminder of the danger signs ("red flags") for the presence of serious underlying disorders that can cause acute or sub-acute headache : ●Systemic symptoms, illness, or condition (eg, fever, weight loss, cancer, pregnancy, immunocompromised state including HIV). ●Neurologic symptoms or abnormal signs (eg, confusion, impaired alertness or consciousness, papilledema, focal neurologic symptoms or signs, meningismus, or seizures). ●Onset is new (particularly for age >40 years) or sudden (eg, "thunderclap"). ●Other associated conditions or features (eg, head trauma, illicit drug use, or toxic exposure; headache. awakens from sleep, is worse with Valsalva maneuvers, or is precipitated by cough, exertion, or sexual activity). ●Previous headache history with headache progression or change in attack frequency, severity, or clinical features.
  • 14.
  • 15. TENSION HEADACHE • The usual abortive treatment can be any simple analgesic (aspirin, NSAIDs, acetaminophen). The most effective prophylactic drug is amitriptyline in the dosage of 50–150 mg per day. Lower dosage may be tried initially. MIGRAINE HEADACHE • There are certain specific treatments for migraines, which are given as follows: • • Analgesics: Aspirin, acetaminophen • • NSAIDs: Naproxen, ibuprofen • • 5-HT1 agonists-oral: Ergotamine, rizatriptan, naratriptan, zolmitriptan • • 5-HT1 agonists-nasal: Dihydroergotamine, sumatriptan, zolmitriptan • • 5-HT1 agonists-parenteral: Dihydroergotamine, sumatriptan • • Dopamine antagonists: Metoclopramide, prochlorperazine.
  • 16. CLUSTER HEADACHE • Nasal oxygen (8–10 L/min), sumatriptan (subcutaneous 6 mg) and dihydroergotamine (subcutaneous or intramuscular). • The maintenance prophylactic agents include calcium channel blockers (verapamil 80 mg three times a day to a maximum dose of 720 mg per day; monitor with ECG if total daily dose is more than 480 mg/ day), methylsergide, lithium (300 mg three times daily; monitor with lithium levels), topiramate (100–400 mg/day), gabapentine (1,200–3,600 mg/day), melatonin (9–12 mg/day).
  • 18. Acute peripheral CN VII (facial nerve) palsy of unknown cause. However, the terms "Bell's palsy" and "idiopathic facial paralysis" may no longer be considered. A peripheral facial palsy is a clinical syndrome of many causes.
  • 19. Sir Charles Bell, Scottish Surgeon First described in early 1800s based on trauma to facial nerves.
  • 20.
  • 21. Bell's palsy, defined as an acute peripheral facial nerve palsy of unknown cause, represents about half of all cases of facial nerve palsy . The annual incidence rate is between 13 and 34 cases per 100,000 population . There is no race, geographic, or gender predilection, but the risk is three times greater during pregnancy, especially in the third trimester or in the first postpartum week. Diabetes is present in about 5 to 10 percent of patients.
  • 22. -Herpes simplex Virus now is widely accepted as most common cause. -Herpes zoster is probably the second most common viral infection associated with facial palsy. -An inactivated intranasal influenza vaccine. -Genetic predisposition in some cases. -Diabetes is a risk factor for microangiopathy. -The increased risk of Bell’s palsy associated with pregnancy, which is most marked in the third trimester and the first postpartum week, may be caused by pregnancy-related fluid retention leading to compression of the nerve or perineural edema.
  • 23. -Patients with Bell's palsy typically present with the sudden onset (usually over hours) of unilateral facial paralysis. -Common findings include the eyebrow sagging, inability to close the eye, disappearance of the nasolabial fold, and drooping at the affected corner of the mouth, which is drawn to the unaffected side. -Decreased tearing, hyperacusis, and/or loss of taste sensation on the anterior two-thirds of the tongue may help to site the lesion in the fallopian canal, but these findings are of little practical use other than as indicators of severity. -patients had bilateral facial palsy, possibly from the same pathogenesis as typical unilateral Bell's palsy. Examination : Facial movement is assessed by observing the response to command for closing the eyes, elevating the brow, frowning, showing the teeth, puckering the lips, and tensing the soft tissues of the neck to observe for platysma activation. The evaluation also includes a general physical examination and neurologic examination. Particular attention is directed at the external ear to look for vesicles or scabbing (which indicates zoster) and for mass lesions within the parotid gland.
  • 24. Thus, dissociation of movement of the face to command from spontaneous movement, as in smiling, indicates an upper motor neuron lesion. Lack of dissociation (absence of both voluntary and spontaneous movement) indicates a lower motor neuron (peripheral) lesion.
  • 25. -Herpes zoster (Ramsey Hunt syndrome). -Otitis media. -Lyme disease: could be Bilateral. -Guillain-Barré syndrome: could be bilateral. -HIV infection: could be bilateral. -Sarcoidosis: could be bilateral. -Tumor. -Trauma. -Stroke.
  • 26. • oral glucocorticoids for all patients with idiopathic facial nerve palsy (Bell's palsy) or facial nerve palsy of suspected viral etiology, consistent with current guidelines. Treatment should preferably begin within three days of symptom onset. Our suggested regimen is prednisone (60 to 80 mg/day) for one week. • The suspicion that Bell's palsy is caused by herpes simplex virus in most patients led to trials of antiviral therapy. • Suggested early combined therapy with prednisone (60 to 80 mg per day) plus valacyclovir (1000 mg three times daily) for one week for patients with severe facial palsy at presentation. • Eye care In severe cases of Bell's palsy, the cornea may be at risk because of poor eye lid closure and reduced tearing.
  • 27. • The prognosis of Bell's palsy is related to the severity of the lesion. A simple rule is that clinically incomplete lesions tend to recover. • The prognosis is favorable if some recovery is seen within the first 21 days of onset. A diagnosis of Bell's palsy is doubtful if some facial function, however small, has not returned within three to four months.
  • 29. Seizures are a common occurrence, affecting an estimated 8 to 10 percent of the population over a lifetime. Seizures account for 1 to 2 percent of all emergency department visits, and approximately one-quarter of these will be a first seizure
  • 30. A seizure is a sudden change in behavior caused by electrical hypersynchronization of neuronal networks in the cerebral cortex. • Acute symptomatic seizure — Refers to a seizure that occurs at the time of a systemic insult or in close temporal association with a documented brain insult . Such insults include metabolic derangements, drug or alcohol withdrawal, and acute neurologic disorders such as stroke, encephalitis, or acute head injury. • Unprovoked seizure — Refers to a seizure of unknown etiology as well as one that occurs in relation to a preexisting brain lesion or progressive nervous system disorder. Unprovoked seizures that are determined to be due to an underlying brain lesion or disorder are also referred to as remote symptomatic seizures. They carry a higher risk of future epilepsy compared with acute symptomatic seizures.
  • 31. -Focal seizures with retained awareness — The symptoms of focal seizures with retained awareness (previously called simple partial seizures) vary from one patient to another and depend entirely on the part of the cortex that is disrupted at the onset of the seizure. -Focal seizures with impaired awareness — Some focal seizures are associated with altered awareness at the onset of the seizure or as it progresses. These seizures, previously called complex partial seizures, are the most common type of seizure in adults with epilepsy. -Generalized seizures — Generalized tonic-clonic seizures (also called grand mal seizures, major motor seizures, or convulsions) are the most common type of generalized seizures.
  • 32. Seizure is primarily a clinical diagnosis, and accurate diagnosis requires differentiating seizure from other common clinical events that can mimic seizure. In adults, the primary conditions to consider in patients presenting with transient or paroxysmal neurologic events are ●Syncope ●Transient ischemic attack (particularly in older adults) ●Migraine ●Panic attack and anxiety ●Psychogenic nonepileptic seizure ●Paroxysmal movement disorders
  • 33. Medical history Description of the event Postictal period Seizure precipitants or triggers Prior events Medications and substances Past medical history Family history Physical and neurologic examination Laboratories Electrocardiogram ADDITIONAL TESTING
  • 34. Early postseizure management — Most seizures remit spontaneously within two minutes and rapid administration of a benzodiazepine or antiseizure drug is not required. Nonetheless, intravenous access is typically secured by paramedics or in the emergency department setting for patients presenting acutely so that parenteral medications can be administered if the seizure is more prolonged or recurs. When to start antiseizure drug therapy — The decision whether to start antiseizure drug therapy immediately after a first seizure depends on multiple factors, including the probability that the event represented a seizure, the suspected or confirmed cause of the seizure based on the initial evaluation, the stability of the patient, and the estimated risk of recurrent seizure. Indications for hospitalization — Hospitalization may be required for patients who have a first seizure associated with a prolonged postictal state, incomplete recovery, or serious seizure-related injury. Other indications for hospitalization include status epilepticus, the presence of a neurologic or systemic illness or insult requiring additional evaluation and treatment, or questions regarding compliance.
  • 35.